help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 23, 2003
Endocrinology, doi:10.1210/en.2003-0829
A more recent version of this article appeared on February 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/2/519    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laurent, V.
Right arrow Articles by Lindberg, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laurent, V.
Right arrow Articles by Lindberg, I.

Submitted on July 3, 2003
Accepted on October 14, 2003

Biosynthesis of POMC-derived peptides in prohormone convertase 2 and 7B2 null mice

Virginie Laurent1, Lisa Jaubert-Miazza1, Roxane Desjardins1, Robert Day1, and Iris Lindberg1*

1 Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, New Orleans, LA 70112. Département de Pharmacologie, Faculté de Mèdecine et Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada, JIH 5N4

* To whom correspondence should be addressed. E-mail: ilindb{at}LSUHSC.edu.

Prohormone convertases are thought to represent the major proteinases involved in the biosynthetic processing of peptide hormone precursors to bioactive peptide products. The maturation of prohormone convertase 2 (PC2) requires the aid of a helper protein, 7B2, in order for the zymogen to become an active enzyme species. The 7B2 and PC2 nulls should thus be functionally equivalent with regard to deficits in precursor processing. In this report, we have examined this proposition through the study of POMC biosynthesis and granule content in both null models. RIA data indicate that both PC2 and 7B2 nulls lack pituitary {alpha}-MSH; interestingly, 7B2 nulls are still able to generate {beta}-endorphin from {beta}-LPH, while PC2 nulls contain little if any {beta}-endorphin. Labeling experiments demonstrate a build-up of POMC, high molecular weight intermediates, and intact ACTH, as well as the disappearance of {alpha}-MSH, in both null models. Electron microscopy of neurointermediate lobe melanotrophs reveals the presence of a significantly greater number of secretory granules in both 7B2 and PC2 nulls compared with wild-type controls. However, PC2 null melanotrophs contain twice as many granules as do 7B2 null melanotrophs. Another difference between the two null models is a relatively enhanced accumulation of precursors in the PC2 null compared with the7B2 null; these include not only PC2 substrates, but also presumed PC1 substrates. These data indicate that the two nulls are not phenotypically equivalent.


Key words: POMC • prohormone convertase • pituitary • ACTH • PC2 • 7B2







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society